237 related articles for article (PubMed ID: 31406047)
1. [Next generation zebrafish-based drug discovery and precision medicine].
Tanaka T; Koiwa J
Nihon Yakurigaku Zasshi; 2019; 154(2):78-83. PubMed ID: 31406047
[TBL] [Abstract][Full Text] [Related]
2. Zebrafish Xenografts for Drug Discovery and Personalized Medicine.
Xiao J; Glasgow E; Agarwal S
Trends Cancer; 2020 Jul; 6(7):569-579. PubMed ID: 32312681
[TBL] [Abstract][Full Text] [Related]
3. [Cancer cell transplantation in zebrafish: From translational research to personalized medicine].
Raby L; Völkel P; Le Bourhis X; Angrand PO
Bull Cancer; 2020 Jan; 107(1):30-40. PubMed ID: 31466696
[TBL] [Abstract][Full Text] [Related]
4. Zebrafish Avatar to Develop Precision Breast Cancer Therapies.
Corsinovi D; Usai A; Sarlo M; Giannaccini M; Ori M
Anticancer Agents Med Chem; 2022; 22(4):748-759. PubMed ID: 33797388
[TBL] [Abstract][Full Text] [Related]
5. Big data: the next frontier for innovation in therapeutics and healthcare.
Issa NT; Byers SW; Dakshanamurthy S
Expert Rev Clin Pharmacol; 2014 May; 7(3):293-8. PubMed ID: 24702684
[TBL] [Abstract][Full Text] [Related]
6. Personalized
Pauli C; Hopkins BD; Prandi D; Shaw R; Fedrizzi T; Sboner A; Sailer V; Augello M; Puca L; Rosati R; McNary TJ; Churakova Y; Cheung C; Triscott J; Pisapia D; Rao R; Mosquera JM; Robinson B; Faltas BM; Emerling BE; Gadi VK; Bernard B; Elemento O; Beltran H; Demichelis F; Kemp CJ; Grandori C; Cantley LC; Rubin MA
Cancer Discov; 2017 May; 7(5):462-477. PubMed ID: 28331002
[TBL] [Abstract][Full Text] [Related]
7. Omics-Based Strategies in Precision Medicine: Toward a Paradigm Shift in Inborn Errors of Metabolism Investigations.
Tebani A; Afonso C; Marret S; Bekri S
Int J Mol Sci; 2016 Sep; 17(9):. PubMed ID: 27649151
[TBL] [Abstract][Full Text] [Related]
8. The Power of Zebrafish in Personalised Medicine.
Baxendale S; van Eeden F; Wilkinson R
Adv Exp Med Biol; 2017; 1007():179-197. PubMed ID: 28840558
[TBL] [Abstract][Full Text] [Related]
9. Promise of personalized omics to precision medicine.
Chen R; Snyder M
Wiley Interdiscip Rev Syst Biol Med; 2013; 5(1):73-82. PubMed ID: 23184638
[TBL] [Abstract][Full Text] [Related]
10. Zebrafish patient avatars in cancer biology and precision cancer therapy.
Fazio M; Ablain J; Chuan Y; Langenau DM; Zon LI
Nat Rev Cancer; 2020 May; 20(5):263-273. PubMed ID: 32251397
[TBL] [Abstract][Full Text] [Related]
11. Precision medicine and oncology: an overview of the opportunities presented by next-generation sequencing and big data and the challenges posed to conventional drug development and regulatory approval pathways.
Doherty M; Metcalfe T; Guardino E; Peters E; Ramage L
Ann Oncol; 2016 Aug; 27(8):1644-6. PubMed ID: 27117532
[No Abstract] [Full Text] [Related]
12. Genomic Medicine Without Borders: Which Strategies Should Developing Countries Employ to Invest in Precision Medicine? A New "Fast-Second Winner" Strategy.
Mitropoulos K; Cooper DN; Mitropoulou C; Agathos S; Reichardt JKV; Al-Maskari F; Chantratita W; Wonkam A; Dandara C; Katsila T; Lopez-Correa C; Ali BR; Patrinos GP
OMICS; 2017 Nov; 21(11):647-657. PubMed ID: 29140767
[TBL] [Abstract][Full Text] [Related]
13. Using zebrafish models of leukemia to streamline drug screening and discovery.
Deveau AP; Bentley VL; Berman JN
Exp Hematol; 2017 Jan; 45():1-9. PubMed ID: 27720937
[TBL] [Abstract][Full Text] [Related]
14. Fishing the targets of myeloid malignancies in the era of next generation sequencing.
Shi X; He BL; Ma AC; Leung AY
Blood Rev; 2016 Mar; 30(2):119-30. PubMed ID: 26443083
[TBL] [Abstract][Full Text] [Related]
15. Hooking the big one: the potential of zebrafish xenotransplantation to reform cancer drug screening in the genomic era.
Veinotte CJ; Dellaire G; Berman JN
Dis Model Mech; 2014 Jul; 7(7):745-54. PubMed ID: 24973744
[TBL] [Abstract][Full Text] [Related]
16. Facilitating tailored therapeutic strategies for glioblastoma through an orthotopic patient-derived xenograft platform.
Lee HW; Lee K; Kim DG; Yang H; Nam DH
Histol Histopathol; 2016 Mar; 31(3):269-83. PubMed ID: 26578300
[TBL] [Abstract][Full Text] [Related]
17. Spatiotemporal diversification of intrapatient genomic clones and early drug development concepts realize the roadmap of precision cancer medicine.
Roukos DH
Drug Discov Today; 2017 Aug; 22(8):1148-1164. PubMed ID: 28400153
[TBL] [Abstract][Full Text] [Related]
18. Strategy of Daiichi Sankyo discovery research in oncology.
Akahane K; Hirokawa K
Jpn J Clin Oncol; 2014 Feb; 44(2):109-15. PubMed ID: 24459194
[TBL] [Abstract][Full Text] [Related]
19. Making individualized drugs a reality.
Schellekens H; Aldosari M; Talsma H; Mastrobattista E
Nat Biotechnol; 2017 Jun; 35(6):507-513. PubMed ID: 28581491
[No Abstract] [Full Text] [Related]
20. Orphan diseases: state of the drug discovery art.
Volmar CH; Wahlestedt C; Brothers SP
Wien Med Wochenschr; 2017 Jun; 167(9-10):197-204. PubMed ID: 26819216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
